Efficacy, Safety, and Tolerability of Pridopidine in Huntington Disease (HD): Results from the Phase II, Double-blind, Placebo-controlled, Dose-Ranging Study, Pride-HD (P2.005)

Karl Kieburtz, Michael R. Hayden, Beth Borowsky et al.|Neurology|2017

Cited by 10